Application of Lung Ultrasound During the COVID-19 Pandemic: A Narrative Review

Anesth Analg. 2020 Aug;131(2):345-350. doi: 10.1213/ANE.0000000000004929.

Abstract

This review highlights the ultrasound findings reported from a number of studies and case reports and discusses the unifying findings from coronavirus disease (COVID-19) patients and from the avian (H7N9) and H1N1 influenza epidemics. We discuss the potential role for portable point-of-care ultrasound (PPOCUS) as a safe and effective bedside option in the initial evaluation, management, and monitoring of disease progression in patients with confirmed or suspected COVID-19 infection.

Publication types

  • Review

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Betacoronavirus / pathogenicity*
  • COVID-19
  • Coronavirus Infections / diagnostic imaging*
  • Coronavirus Infections / therapy
  • Coronavirus Infections / transmission
  • Coronavirus Infections / virology
  • Female
  • Humans
  • Infection Control
  • Infectious Disease Transmission, Patient-to-Professional / prevention & control
  • Influenza A Virus, H1N1 Subtype / pathogenicity
  • Influenza A Virus, H7N9 Subtype / pathogenicity
  • Influenza, Human / diagnostic imaging
  • Influenza, Human / virology
  • Lung / diagnostic imaging*
  • Lung / virology
  • Male
  • Middle Aged
  • Occupational Exposure / adverse effects
  • Occupational Exposure / prevention & control
  • Pandemics
  • Pneumonia, Viral / diagnostic imaging*
  • Pneumonia, Viral / therapy
  • Pneumonia, Viral / transmission
  • Pneumonia, Viral / virology
  • Point-of-Care Systems*
  • Point-of-Care Testing*
  • Predictive Value of Tests
  • Prognosis
  • Risk Factors
  • SARS-CoV-2
  • Ultrasonography* / adverse effects